Cargando…

The Impact of Lipoprotein-Associated Oxidative Stress on Cell-Specific Microvesicle Release in Patients with Familial Hypercholesterolemia

Objective. Microvesicles (MVs) are small cell-derived particles shed upon activation. Familial hypercholesterolemia (FH) particularly when associated with Achilles tendon xanthomas (ATX) predisposes to atherosclerosis, possibly through oxLDL-C interaction with the CD36 receptor. To investigate the h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nielsen, M. H., Irvine, H., Vedel, S., Raungaard, B., Beck-Nielsen, H., Handberg, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748106/ https://www.ncbi.nlm.nih.gov/pubmed/26925191 http://dx.doi.org/10.1155/2016/2492858

Ejemplares similares

Elevated Atherosclerosis-Related Gene Expression, Monocyte Activation and Microparticle-Release Are Related to Increased Lipoprotein-Associated Oxidative Stress in Familial Hypercholesterolemia
por: Hjuler Nielsen, Morten, et al.
Publicado: (2015)

In vitro Incubation of Platelets with oxLDL Does Not Induce Microvesicle Release When Measured by Sensitive Flow Cytometry
por: Nielsen, Tine Bo, et al.
Publicado: (2015)

Improvement of oxidative stress status by lipoprotein apheresis in Chinese patients with familial hypercholesterolemia
por: Wen, Jun, et al.
Publicado: (2019)

Familial Hypercholesterolemia and Lipoprotein Apheresis
por: Makino, Hisashi, et al.
Publicado: (2019)

Lipoprotein metabolism in familial hypercholesterolemia
por: Chemello, Kévin, et al.
Publicado: (2021)

Increased extracellular vesicles (EVs) related to T cell-mediated inflammation and vascular function in familial hypercholesterolemia
por: Nielsen, Morten Hjuler, et al.
Publicado: (2023)

BLTR1 and CD36 Expressing Microvesicles in Atherosclerotic Patients and Healthy Individuals
por: Sanden, Mathilde, et al.
Publicado: (2018)

Bariatric surgery reduces CD36-bearing microvesicles of endothelial and monocyte origin
por: Botha, Jaco, et al.
Publicado: (2018)

Evaluation of Oxidative Stress Status in Familial Hypercholesterolemia
por: Ganjali, Shiva, et al.
Publicado: (2021)

Pregnancy in a Woman with Homozygous Familial Hypercholesterolemia Not on Low-Density Lipoprotein Apheresis
por: Fahed, Akl C., et al.
Publicado: (2012)

Lipids, lipoproteins and prevalence of familial hypercholesterolemia in the Faroe Islands – Results from a nationwide laboratory database
por: Borg, Sanna á, et al.
Publicado: (2022)

Lipoprotein-apheresis reduces circulating microparticles in individuals with familial hypercholesterolemia
por: Connolly, Katherine D., et al.
Publicado: (2014)

Elevated Lipoprotein(a) Level Influences Familial Hypercholesterolemia Diagnosis
por: Chubykina, Uliana V., et al.
Publicado: (2022)

Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia
por: Olmastroni, Elena, et al.
Publicado: (2023)

Microvesicles Correlated with Components of Metabolic Syndrome in Men with Type 2 Diabetes Mellitus and Lowered Testosterone Levels But Were Unaltered by Testosterone Therapy
por: Botha, Jaco, et al.
Publicado: (2017)

Relation of Serum Lipoprotein(a) Levels to Lipoprotein and Apolipoprotein Profiles and Atherosclerotic Diseases in Japanese Patients with Heterozygous Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study
por: Naito, Ryo, et al.
Publicado: (2022)

Cross-Talk between Lipoproteins and Inflammation: The Role of Microvesicles
por: Chiva-Blanch, Gemma, et al.
Publicado: (2019)

Risk of cardiovascular disease with lipoprotein(a) in familial hypercholesterolemia: a review
por: Watanabe, Jun, et al.
Publicado: (2020)

A modified algorithm with lipoprotein(a) added for diagnosis of familial hypercholesterolemia
por: Sun, Di, et al.
Publicado: (2019)

Familial Hypercholesterolemia and Lipoprotein(a): A Gordian Knot in Cardiovascular Prevention
por: Koutsogianni, Amalia Despoina, et al.
Publicado: (2022)

Systematic Review of Low‐Density Lipoprotein Cholesterol Apheresis for the Treatment of Familial Hypercholesterolemia
por: Wang, Anthony, et al.
Publicado: (2016)

Lipoprotein(a) and Familial Hypercholesterolemia: A Short Review Including the Laboratory Viewpoint
por: Hamasaki, Masato, et al.
Publicado: (2020)

Effects of statins on the inducible degrader of low-density lipoprotein receptor in familial hypercholesterolemia
por: Chan, Melody Lok-Yi, et al.
Publicado: (2022)

Synergistic effect of lipoprotein (a) and C-reactive protein on prognosis of familial hypercholesterolemia
por: Tada, Hayato, et al.
Publicado: (2022)

Does low-density lipoprotein fully explain atherosclerotic risk in familial hypercholesterolemia?
por: Clarke, Shoa L.
Publicado: (2023)

Microvesicle Formation Induced by Oxidative Stress in Human Erythrocytes
por: Sudnitsyna, Julia, et al.
Publicado: (2020)

Analysis of sequence variations in low-density lipoprotein receptor gene among Malaysian patients with familial hypercholesterolemia
por: Al-Khateeb, Alyaa, et al.
Publicado: (2011)

Familial Hypercholesterolemia Prevalence Among Ethnicities—Systematic Review and Meta-Analysis
por: Toft-Nielsen, Frida, et al.
Publicado: (2022)

Familial hypercholesterolemia class II low-density lipoprotein receptor response to statin treatment
por: Omer, Linda, et al.
Publicado: (2020)

Why continued lipoprotein apheresis is vital for homozygous familial hypercholesterolemia patients with COVID-19
por: Vuorio, Alpo, et al.
Publicado: (2021)

Familial hypercholesterolemia: The skin speaks
por: Johnson, Johns T., et al.
Publicado: (2020)

Familial Hypercholesterolemia
por: Baruah, Dibya Kumar
Publicado: (2021)

Familial hypercholesterolemia in St.-Petersburg: the known and novel mutations found in the low density lipoprotein receptor gene in Russia
por: Zakharova, Faina M, et al.
Publicado: (2005)

Lipoprotein metabolism in familial hypercholesterolemia: Serial assessment using a one-step ultracentrifugation method
por: Tada, Hayato, et al.
Publicado: (2015)

Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia
por: Trinder, Mark, et al.
Publicado: (2020)

Familial Hypercholesterolemia and Elevated Lipoprotein(a): Cascade Testing and Other Implications for Contextual Models of Care
por: Loh, Wann Jia, et al.
Publicado: (2022)

Analysis of the low density lipoprotein receptor gene (LDLR) mutation spectrum in Russian familial hypercholesterolemia
por: Vasilyev, V.B., et al.
Publicado: (2022)

Characterization of Polyvascular Disease in Heterozygous Familial Hypercholesterolemia: Its Association With Circulating Lipoprotein(a) Levels
por: Funabashi, Sayaka, et al.
Publicado: (2022)

Low-density lipoprotein receptor genotypes modify the sera metabolome of patients with homozygous familial hypercholesterolemia
por: Du, Zhiyong, et al.
Publicado: (2022)

Genetically confirmed familial hypercholesterolemia in outpatients with hypercholesterolemia
por: Wang, Xu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jltg2ou5mht0u46gg082f5ovte